These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 26199728)

  • 21. Comparative analysis of various tumor-associated antigen-specific t-cell responses in patients with hepatocellular carcinoma.
    Mizukoshi E; Nakamoto Y; Arai K; Yamashita T; Sakai A; Sakai Y; Kagaya T; Yamashita T; Honda M; Kaneko S
    Hepatology; 2011 Apr; 53(4):1206-16. PubMed ID: 21480325
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Generation of antitumor response against hepatocellular carcinoma by in vitro transduction of dendritic cells with adeno-associated virus expressing α-fetoprotein].
    Du WZ; Yu TX
    Zhonghua Yi Xue Za Zhi; 2011 Aug; 91(29):2077-80. PubMed ID: 22093940
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Elicitation of both CD4 and CD8 T-cell-mediated specific immune responses to HCA587 protein by autologous dendritic cells.
    Li B; He X; Pang X; Zhang H; Chen J; Chen W
    Scand J Immunol; 2004 Nov; 60(5):506-13. PubMed ID: 15541044
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cirrhotic patients with or without hepatocellular carcinoma harbour AFP-specific T-lymphocytes that can be activated in vitro by human alpha-fetoprotein.
    Hanke P; Rabe C; Serwe M; Böhm S; Pagenstecher C; Sauerbruch T; Caselmann WH
    Scand J Gastroenterol; 2002 Aug; 37(8):949-55. PubMed ID: 12229971
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Immunization with dendritic cells infected with human AFP adenovirus vector effectively elicits immunity against mouse hepatocellular carcinomas].
    Tan XH; Zhu Q; Liu C; Liu XL; Shao XT; Wei B
    Zhonghua Zhong Liu Za Zhi; 2006 Jan; 28(1):13-6. PubMed ID: 16737612
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immunotherapy of murine hepatocellular carcinoma by alpha-fetoprotein DNA vaccination combined with adenovirus-mediated chemokine and cytokine expression.
    Rodríguez MM; Ryu SM; Qian C; Geissler M; Grimm C; Prieto J; Blum HE; Mohr L
    Hum Gene Ther; 2008 Jul; 19(7):753-9. PubMed ID: 18549308
    [TBL] [Abstract][Full Text] [Related]  

  • 27. T-cell responses to HLA-A*0201 immunodominant peptides derived from alpha-fetoprotein in patients with hepatocellular cancer.
    Butterfield LH; Ribas A; Meng WS; Dissette VB; Amarnani S; Vu HT; Seja E; Todd K; Glaspy JA; McBride WH; Economou JS
    Clin Cancer Res; 2003 Dec; 9(16 Pt 1):5902-8. PubMed ID: 14676113
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nonspecific CD4(+) T cells with uptake of antigen-specific dendritic cell-released exosomes stimulate antigen-specific CD8(+) CTL responses and long-term T cell memory.
    Hao S; Yuan J; Xiang J
    J Leukoc Biol; 2007 Oct; 82(4):829-38. PubMed ID: 17626150
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Spontaneous tumor-specific humoral and cellular immune responses to NY-ESO-1 in hepatocellular carcinoma.
    Korangy F; Ormandy LA; Bleck JS; Klempnauer J; Wilkens L; Manns MP; Greten TF
    Clin Cancer Res; 2004 Jul; 10(13):4332-41. PubMed ID: 15240519
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Alpha-fetoprotein specific CD4 and CD8 T cell responses in patients with hepatocellular carcinoma.
    Behboudi S; Pereira SP
    World J Hepatol; 2010 Jul; 2(7):256-60. PubMed ID: 21161007
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Generation of CD4(+) and CD8(+) T lymphocyte responses by dendritic cells armed with PSA/anti-PSA (antigen/antibody) complexes.
    Berlyn KA; Schultes B; Leveugle B; Noujaim AA; Alexander RB; Mann DL
    Clin Immunol; 2001 Dec; 101(3):276-83. PubMed ID: 11726219
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dendritic cells pulsed with alpha-fetoprotein and mutant P53 fused gene induce bi-targeted cytotoxic T lymphocyte response against hepatic carcinoma.
    Ren J; Jia J; Zhang H; Zhang L; Ma B; Jiang H; Di L; Song G; Yu J
    Cancer Sci; 2008 Jul; 99(7):1420-6. PubMed ID: 18422751
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A phase I/II trial testing immunization of hepatocellular carcinoma patients with dendritic cells pulsed with four alpha-fetoprotein peptides.
    Butterfield LH; Ribas A; Dissette VB; Lee Y; Yang JQ; De la Rocha P; Duran SD; Hernandez J; Seja E; Potter DM; McBride WH; Finn R; Glaspy JA; Economou JS
    Clin Cancer Res; 2006 May; 12(9):2817-25. PubMed ID: 16675576
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Glycoprotein 96 and α-fetoprotein cross-linking complexes elicited specific antitumor immunity.
    Wang XP; Wang QX; Lin HP; Wang YL; Yang Y
    Cancer Biother Radiopharm; 2013 Jun; 28(5):406-14. PubMed ID: 23484810
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dendritic cells transduced with tumor-associated antigen gene elicit potent therapeutic antitumor immunity: comparison with immunodominant peptide-pulsed DCs.
    Nakamura M; Iwahashi M; Nakamori M; Ueda K; Ojima T; Naka T; Ishida K; Yamaue H
    Oncology; 2005; 68(2-3):163-70. PubMed ID: 16006753
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The use of dendritic cells for peptide-based vaccination in cancer immunotherapy.
    Salem ML
    Methods Mol Biol; 2014; 1139():479-503. PubMed ID: 24619701
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Specific antitumor immunity induced by cross-linking complex heat shock protein 72 and alpha-fetoprotein.
    Wang XP; Lin HP; Wang QX; Gu Y
    Cancer Biother Radiopharm; 2012 Apr; 27(3):189-97. PubMed ID: 22372558
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A hepatocellular carcinoma-specific adenovirus variant, CV890, eliminates distant human liver tumors in combination with doxorubicin.
    Li Y; Yu DC; Chen Y; Amin P; Zhang H; Nguyen N; Henderson DR
    Cancer Res; 2001 Sep; 61(17):6428-36. PubMed ID: 11522637
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Co-transfection of dendritic cells with AFP and IL-2 genes enhances the induction of tumor antigen-specific antitumor immunity.
    Yang JY; Li X; Gao L; Teng ZH; Liu WC
    Exp Ther Med; 2012 Oct; 4(4):655-660. PubMed ID: 23170121
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cross-presentation through langerin and DC-SIGN targeting requires different formulations of glycan-modified antigens.
    Fehres CM; Kalay H; Bruijns SC; Musaafir SA; Ambrosini M; van Bloois L; van Vliet SJ; Storm G; Garcia-Vallejo JJ; van Kooyk Y
    J Control Release; 2015 Apr; 203():67-76. PubMed ID: 25656175
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.